Biologic data exclusivity: The arguments for and against it

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology:

Why data exclusivity is the new patent protection
Peter J Pitts, Center for medicine in the public interest

Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski(a) and Elizabeth A Jex(b)
a) Office of Policy Planning, Federal Trade Commission
b) FTC Office of Policy Planning

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

October 20, 2009

20 Oct 2009

Kyoto Prize Journalism Fellowship

I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.

This fellowship will allow me to attend the Kyoto Prize Ceremony, laureate lectures and workshops, and associated functions. The Kyoto Prize is one of the world’s most prestigious awards given to those who have made outstanding lifetime achievements in technology, science, or the arts. This year’s laureates are:

Dr. Isamu Akasaki, Blue LED pioneer

Drs. Peter and Rosemary Grant, Evolutionary Biologists

Pierre Boulez, World-renowned composer, conductor

I am honored to have the opportunity to attend this prestigious event and to learn more about innovation in diverse disciplines.

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology, Talks and Publications

October 2, 2009

02 Oct 2009

Drug Patent Expirations in October 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in October 2009

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
BREATHTEK UBT FOR H-PYLORI	Otsuka America	urea, c-13	4,830,010	Oct 27, 2009
CEDAX	Sciele Pharma Inc	ceftibuten dihydrate	4,634,697	Oct 1, 2009
COLGATE TOTAL	Colgate Palmolive	sodium fluoride; triclosan	5,156,835	Oct 20, 2009
COVERA-HS	Gd Searle Llc	verapamil hydrochloride	5,785,994	Oct 22, 2009
DOXIL	Ortho Biotech	doxorubicin hydrochloride	5,013,556	Oct 20, 2009
DOXIL	Ortho Biotech	doxorubicin hydrochloride	5,213,804	Oct 20, 2009
FLOMAX	Boehringer Ingelheim	tamsulosin hydrochloride	4,703,063	Oct 27, 2009
INVEGA SUSTENNA	Johnson And Johnson	paliperidone palmitate	5,254,556	Oct 27, 2009
MERETEK UBT KIT (W/ PRANACTIN)	Otsuka America	urea, c-13	4,830,010	Oct 27, 2009
PERMAX	Valeant Pharm Intl	pergolide mesylate	5,114,948	Oct 19, 2009